|
Time
|
Program
|
Chairs
|
|
09:00—9:15
|
Opening Ceremony
1. Welcome
address by Yongxiang Zhang, CNPHARS President
2. Opening
speech by Satomi Akahane, JPS President
3. Opening
speech by delegate from JSCPT
4. Opening
speech by Fumiyoshi Yamashita, JSSX President
|
Chaoyu
Miao
|
|
Young Scientist Presentation
|
|
09:15—09:30
|
Junichi Kikuta, Osaka
University, Japan
Intravital imaging of in vivo pharmacological actions of
drugs on the immune system
|
Tomoyoki
Furuyashiki
Yong
Zhang
|
|
09:30—09:45
|
Xiao Li, Hangzhou
Institute for Advanced Study, University of Chinese Academy of Sciences,
China
Spermine Is a Natural Suppressor of
AR Signaling in Castration-Resistant Prostate Cancer
|
|
09:45—10:00
|
Kazuhiro Nishiyama, Osaka
Metropolitan University, Japan
Drug discovery research targeting
functional modification of G protein-coupled receptors
|
|
10:00—10:15
|
Sili Zheng, Naval
Medical University, China
Endothelial METRNL determines
circulating METRNL level and maintains endothelial function against
atherosclerosis
|
|
10:15—10:30
|
Group
photo and Tea break
|
|
10:30—10:45
|
Hirofumi Hamano, Okayama
University Hospital, Japan
Investigating the Preventive
Potential of Pre-existing Pharmacological Drug Against Cisplatin-Induced
Nephrotoxicity
|
Norio
Furukori
Fang
Wang
|
|
10:45—11:00
|
Qingfeng He, Fudan University, China
Insights into Drug-Drug Interactions
of Henagliflozin through Physiologically-based Pharmacokinetic Modeling
|
|
11:00—11:15
|
Toshinori Hirai, Mie University Hospital, Japan
Dose optimization of digoxin in
patients with heart failure and atrial fibrillation
|
|
11:15—11:30
|
Guangyan Mu, Peking
University First Hospital, China
Identification of genetic biomarkers
associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese
healthy volunteers
|
|
11:30—14:00
|
Lunch &
Poster presentations
|
|
Symposium 1
Pharmacology
towards new therapeutics: lessons from biological systems
and natural products
|
|
14:00—14:30
|
Feng Han, Nanjing
Medical University, China
Research progress on the
pharmacological mechanism of natural products in brain diseases
|
Hitoshi
Hashimoto
Jianping
Zuo
|
|
14:30—15:00
|
Rieko Muramatsu, National Institute of Neuroscience,
National Center of Neurology and Psychiatry, Japan
Systemic environments regulate
central nervous system regeneration
|
|
15:00—15:30
|
Junke Song, Institute
of Materia Medica, Chinese Academy of Medical Sciences, China
A study of the effects of baicalein
in the treatment of COVID-19
|
|
15:30—16:00
|
Takahiro Masuda, Kyushu University, Japan
Novel insights into the ontogeny and
diversity of CNS macrophages
|
|
Symposium 2
New developments
in clinical pharmacology for overcoming diverse diseases
|
|
16:00—16:30
|
Wei Zhao, Shandong University, China
Model-Informed Drug Development:
Innovative Approach in Early Phase Clinical Trials
|
Yuji
Kumagai
Zhaoqian
Liu
|
|
16:30—17:00
|
Junji Saruwatari, Kumamoto University, Japan
Clinical Pharmacology Research for
Precision Medicine in Epilepsy
|
|
17:00—17:30
|
Xiaocong Pang, Peking University First Hospital,
China
Mechanisms of SPP1/αvβ3 axis mediated
enzalutamide resistance in castration-resistant prostate cancer and
therapeutic strategy
|
|
17:30—18:00
|
Reo Tanoshima, Yokohama City University Hospital, Japan
Unique Aspects of Pediatric Clinical
Pharmacology
|
|
Symposium 3
DMPK
research facilitating treatment of diseases: new insights, new techniques
|
|
13:30—13:40
|
Speech by the CSSX President, Dr. Chuan Li
Speech by the JSSX President, Dr. Fumiyoshi Yamashita
|
Ling
Yang
|
|
13:40—14:05
|
Koji Chiba, Yokohama University of Pharmacy,
Japan
Exploratory use of physiologically
based pharmacokinetic models -Possibility of novel drug transportation
mechanism
|
Ling
Yang
|
|
14:05—14:30
|
Chuan Li, Shanghai Institute of Materia Medica,
Chinese Academy of Sciences, China
Pharmacokinetic-based research on
pharmacologically active compounds of XueBiJing, a Chinese herbal medicine
for sepsis care
|
Kouichi
Yoshinari
|
|
14:30—14:55
|
Tomomi Furihata, Tokyo University of Pharmacy and Life
Sciences, Japan
Development and characterization of
microphysiological system-based human blood-brain barrier models as key tools
for central nervous system drug development
|
Su
Zeng
|
|
14:55—15:20
|
Yan Wang, Institute of Materia Medica, Chinese
Academy of Medical Sciences, China
Berberine treats atherosclerosis via
down-regulating Choline-TMA-TMAO production pathway in the gut microbiota
|
Fumiyoshi
Yamashita
|
|
15:20—15:30
|
Chenchun Zhong, SCIEX
Company
Bringing it to the next level:
metabolite identification on the ZenoTOF 7600 system
|
Su
Zeng
|
|
15:30—15:40
|
Break
|
|
15:40—16:05
|
Hidenori Ando, Tokushima University, Japan
Therapeutic outcome of
combination treatment with PEGylated liposomal
oxaliplatin and rituximab in B-cell lymphoma-xenograft mouse model
|
Guangbo
Ge
|
|
16:05—16:30
|
Jingkai Gu, Jilin University, China
The biological fate of PEGylated
liposomal doxorubicin nanoparticles
|
Fumiyoshi
Yamashita
|
|
16:30—16:55
|
Masashi Honma, The University of Tokyo Hospital,
Japan
Machine learning approach to predict
cancer cell sensitivity to anti-cancer agents
|
Guorong
Fan
|
|
16:55—17:20
|
Huichang Bi, Southern Medical University, China
Novel role of xenobiotic nuclear
receptors in liver injury and regeneration
|
Kouichi
Yoshinari
|
|
17:20—17:30
|
Concluding talk
|
Hailing
Qiao
|
|
18:00—18:20
|
Closing
Ceremony
|
|
18:30—20:00
|
Dinner
|
京公网安备 11010202007922号
打印